Veracyte Debt to Equity Ratio 2012-2019 | VCYT

Current and historical debt to equity ratio values for Veracyte (VCYT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Veracyte debt/equity for the three months ending March 31, 2019 was 0.15.
Veracyte Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-03-31 $0.01B $0.08B 0.15
2018-12-31 $0.02B $0.08B 0.30
2018-09-30 $0.03B $0.08B 0.32
2018-06-30 $0.03B $0.03B 0.98
2018-03-31 $0.03B $0.03B 0.84
2017-12-31 $0.03B $0.04B 0.68
2017-09-30 $0.03B $0.04B 0.59
2017-06-30 $0.03B $0.05B 0.53
2017-03-31 $0.03B $0.05B 0.48
2016-12-31 $0.03B $0.06B 0.43
2016-09-30 $0.03B $0.03B 0.83
2016-06-30 $0.03B $0.03B 0.73
2016-03-31 $0.02B $0.04B 0.57
2015-12-31 $0.01B $0.05B 0.10
2015-09-30 $0.01B $0.06B 0.09
2015-06-30 $0.01B $0.07B 0.08
2015-03-31 $0.01B $0.04B 0.14
2014-12-31 $0.01B $0.04B 0.12
2014-09-30 $0.00B $0.05B 0.07
2014-06-30 $0.00B $0.05B 0.09
2014-03-31 $0.00B $0.05B 0.09
2013-12-31 $0.01B $0.06B 0.09
2013-09-30 $0.01B $-0.08B -0.06
2013-06-30 $0.01B $-0.07B -0.07
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2011-12-31 $0.00B $-0.04B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.187B $0.092B
Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $114.479B 25.04
Intuitive Surgical (ISRG) United States $59.521B 54.85
Edwards Lifesciences (EW) United States $39.100B 39.07
IDEXX Laboratories (IDXX) United States $24.408B 64.03
Fresenius Medical Care AG KGaA (FMS) Germany $24.241B 15.93
Teleflex (TFX) United States $15.301B 33.15
Olympus (OCPNY) Japan $15.078B 112.82
SONOVA HOLDING (SONVY) Switzerland $14.501B 0.00
Sysmex ADR (SSMXY) Japan $14.145B 38.13
DexCom (DXCM) United States $13.644B 267.59
Hologic (HOLX) United States $12.620B 20.29
STERIS (STE) Ireland $12.544B 30.34
Varian Medical Systems (VAR) United States $12.269B 31.30
ABIOMED (ABMD) United States $11.491B 69.90
Masimo (MASI) United States $8.109B 49.69
Penumbra (PEN) United States $5.895B 249.54
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.153B 38.83
Integra LifeSciences Holdings (IART) United States $4.555B 21.40
Globus Medical (GMED) United States $4.118B 25.68
Tandem Diabetes Care (TNDM) United States $3.627B 0.00
LivaNova (LIVN) United Kingdom $3.564B 23.23
Wright Medical Group (WMGI) Netherlands $3.321B 658.25
Cantel Medical (CMD) United States $3.301B 33.49
Glaukos (GKOS) United States $2.752B 0.00
Integer Holdings (ITGR) United States $2.651B 19.54
Nihon Kohden (NHNKY) Japan $2.366B 23.80
AVANOS MEDICAL, INC (AVNS) United States $1.989B 31.47
Nevro (NVRO) United States $1.941B 0.00
Inogen (INGN) United States $1.360B 30.11
OPKO Health (OPK) United States $1.293B 0.00
Silk Road Medical (SILK) United States $1.252B 0.00
CryoLife (CRY) United States $1.093B 108.41
Tactile Systems Technology (TCMD) United States $1.043B 153.92
Accelerate Diagnostics (AXDX) United States $1.041B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.966B 27.98
Mesa Laboratories (MLAB) United States $0.914B 42.99
Pacific Biosciences Of California (PACB) United States $0.901B 0.00
Luminex (LMNX) United States $0.894B 116.94
ViewRay (VRAY) United States $0.887B 0.00
Natus Medical (BABY) United States $0.887B 20.53
AngioDynamics (ANGO) United States $0.796B 26.10
AxoGen (AXGN) United States $0.764B 0.00
Fluidigm (FLDM) United States $0.752B 0.00
Quotient (QTNT) Switzerland $0.693B 0.00
Intersect ENT (XENT) United States $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.559B 0.00
Corindus Vascular Robotics (CVRS) United States $0.544B 0.00
Si-Bone (SIBN) United States $0.488B 0.00
GenMark Diagnostics (GNMK) United States $0.356B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.351B 18.81
Accuray (ARAY) United States $0.317B 0.00
RTI Surgical (RTIX) United States $0.312B 38.36
TransEnterix (TRXC) United States $0.306B 0.00
Semler Scientific (SMLR) United States $0.291B 57.78
SeaSpine Holdings (SPNE) United States $0.239B 0.00
Neuronetics (STIM) United States $0.231B 0.00
ConforMIS (CFMS) United States $0.231B 0.00
IRadimed (IRMD) United States $0.202B 38.53
Alphatec Holdings (ATEC) United States $0.201B 0.00
CRH Medical (CRHM) Canada $0.199B 69.00
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.172B 0.00
Second Sight Medical Products (EYES) United States $0.101B 0.00
Ekso Bionics Holdings (EKSO) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
Vermillion (VRML) United States $0.083B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
T2 Biosystems (TTOO) United States $0.076B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Spectral Diagnostics (EDTXF) Canada $0.066B 0.00
Helius Medical Technologies (HSDT) United States $0.055B 0.00